TORONTO -- (MARKET WIRE) -- September 15, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced today that two poster presentations of recent Company clinical data will be made at the 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD) (www.easd.org) in Copenhagen, Denmark, September 14 - 17, 2006.
